FDA Leader Awaiting Data on Abortion Pill
What: Despite mifepristone’s long safety record, FDA Commissioner Marty Makary says he’s waiting for more data before guaranteeing continued access.
Key Line: “If the data suggests something… we can’t promise we’re not going to act on that data.”
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Trump promotes IVF access while cutting the team responsible for tracking it.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
Meghan Markle discusses rare and life-threatening postpartum condition on new podcast.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
Researchers call for standardized criteria to assess dangerous placenta conditions.
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
Seventeen GOP-led states aim to dismantle privacy protections for abortion patients; judge questions HIPAA’s constitutionality.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
New report calls women’s health a $360B ‘ghost market’ full of unmet needs across menopause, sexual health, aging, and more.
Once academic, now viral—this disinfectant may be the most powerful skin-safe cleanser yet.
Study identifies fast, simple method for predicting life-threatening postpartum bleeding.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
New Yorker review highlights how fetal rights are becoming the next legal front.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.